Many transgender individuals purchase hormones online because they cannot access proper medical care through official healthcare channels. Research shows that NHS waiting lists for gender services often extend to several years, leaving people without essential treatment during critical periods of their transition.
Evidence indicates that accessing prescribed hormone therapy through conventional routes presents significant barriers. Many GPs lack the training or confidence to prescribe gender-affirming hormones, often referring patients to already overwhelmed specialist services. This creates a healthcare gap where people feel compelled to seek alternatives, despite the risks involved.
Studies demonstrate that online hormone sources frequently provide medications of unknown quality and potentially dangerous dosing regimens. Without proper medical supervision, people may unknowingly use formulations that are inappropriate for their health profile or take doses that could cause serious complications. The lack of monitoring also means that important health checks, such as liver function tests and hormone level assessments, are missed.
Healthcare professionals recognise that the solution lies not in criticising those who seek help wherever they can find it, but in making properly prescribed medication accessible through official healthcare systems. Guidelines emphasise that timely access to appropriate medical care reduces the need for people to take these risks and ensures safer, more effective treatment outcomes for transgender individuals seeking hormone therapy.